Streetbeat News

Products Services

ALPN

Alpine Immune Sciences presented new preclinical data on Povetacicept at the American Association of Neuromuscular & Electrodiagnostic Medicine 2023 Annual Meeting. The data showed that Povetacicept improved disease activity in a model of murine experimental autoimmune myasthenia gravis (EAMG), with clinical scores superior to treatment with either the FcRn inhibitor efgartigimod or an anti-CD20 depleting antibody. In the RUBY-1 clinical trial, Povetacicept was well tolerated in adult healthy volunteers and exhibited dose-related pharmacokinetic and pharmacodynamic effects.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:03 pm

HOWL

SQ

TNON

Block (SQ) shares are trading higher after reporting better-than-expected Q3 results and issuing Q4 guidance. Tenon Medical (TNON) passed a FDA Quality System Inspection Technique Level 2 Inspection. Werewolf Therapeutics (HOWL) presented preliminary data from a Phase 1/1b clinical trial at the Society for Immunotherapy of Cancer's annual meeting.

Portfolio Pulse from ryanfaloona@benzinga.com

November 03, 2023 | 12:54 pm

JFBR

Jeffs' Brands Ltd (NASDAQ:JFBR) has launched a new product line under the Fort Brand, targeting the bedbug outbreak in France. The move comes as the French government increases resources to combat the rising incidence of bedbug infestations ahead of the 2024 Paris Olympics. The company aims to meet the growing demand for effective pest control solutions in various settings, including hotels, trains, and private residences.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:39 pm

ALLG

Allego N.V. (NYSE:ALLG), a pan-European public electric vehicle charging network, has signed two 10-year power purchase agreements (PPAs) with Energy Solutions Group, securing 100 GWh of energy per year. The agreements will provide Allego with renewable energy from a solar park and a wind farm, expected to be operational in January 2024 and January 2025 respectively. This move is expected to stabilize Allego's input cost base and minimize the impact of commodity price volatility on its operational and margin profile.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:36 pm

BCTX

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW) (TSX:BCT) has reported unprecedented anti-tumor activity in tumor models by its next generation breast and prostate cancer immunotherapies. The FDA has authorized Bria-OTS™ Investigational New Drug Application (IND), opening the path to the clinic. The company's data shows broad immune system responses to the next generation immunotherapies compared with those of the earlier formulation. The company expects the administration of personalized BRIA-OTS+™ and BRIA-PROS+™ immunotherapies to provide safe and effective treatment options for cancer patients.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:35 pm

WLDS

Wearable Devices has received a purchase order from a leading Japanese industrial automation company. The amount of the order has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:22 pm

SWAV

Shockwave Medical announced that the US Centers for Medicare & Medicaid Services has established a Category I Current Procedural Terminology Add On Code for Coronary Intravascular Lithotripsy Procedures, effective from January 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:20 pm

VRDN

Viridian Therapeutics has announced that multiple abstracts featuring clinical and preclinical data on its pipeline candidates for Thyroid Eye Disease will be presented at the 2023 Annual Meeting of the American Academy of Ophthalmology.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:15 pm

ATXS

Astria Therapeutics will present new data on STAR-0215 at the 2023 American College of Allergy, Asthma, and Immunology Annual Scientific Meeting.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:15 pm

MTEK

Maris-Tech Ltd. (NASDAQ:MTEK) has received a grant of approximately $156,000 from the Israel Innovation Authority for the second year of a joint development project with the Ben Gurion University. The project aims to develop an AI and machine learning-based system for diagnosing and predicting drone faults and malfunctions. The grant represents 66% of the total budget for the second year operation of the project.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:14 pm